What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review

OBJECTIVE: To investigate the risk of prostate cancer-specific mortality (PCSM) following initial negative systematic transrectal ultrasound-guided (TRUS) prostate biopsies. DESIGN: Systematic review. DATA SOURCES: PubMed and Embase were searched using a string combination with keywords/Medical Subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawa, Sandra Miriam, Benzon Larsen, Signe, Helgstrand, John Thomas, Iversen, Peter, Brasso, Klaus, Røder, Martin Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751212/
https://www.ncbi.nlm.nih.gov/pubmed/33371032
http://dx.doi.org/10.1136/bmjopen-2020-040965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751212/
https://www.ncbi.nlm.nih.gov/pubmed/33371032
http://dx.doi.org/10.1136/bmjopen-2020-040965

Ejemplares similares